ORLANDO, Fla. (Ivanhoe Newswire)- Melanoma — it’s a type of aggressive skin cancer that is the fifth most deadly cancer. Surgery, immunotherapy and chemo are the typical treatments. But now, the FDA has approved a groundbreaking new therapy for patients battling late-stage melanoma, offering hope when options run out.
Whether it’s for fun or for work — we’ve all spent too much time in the sun, but did you know too much sun is the leading cause of melanoma? This year, more than 104,000 people will be told they have it — more than 8,000 will die from the disease.
“For a patient who has late-stage disease, unfortunately, most patients will succumb to their disease,” said Tirrell Johnson, MD, Director of Early Phase Therapeutics at the Orlando Health Cancer Institute…